Financial News
BioNTech to produce vaccines in Singapore, its new regional headquarters
May 10, 2021 at 04:08 AM EDT
The new manufacturing site would be able to produce several hundred of million doses of mRNA-based vaccines per year, depending on the type, BioNTech said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
